Mikhail Titov

Statistics

Publications

Citations

254

H-Index

Active since

2021

Affiliations

Brookhaven National Laboratory(Current)

University of Chicago

Argonne National Laboratory

Oak Ridge National Laboratory

Rutgers, The State University of New Jersey

Mikhail Titov is an author at Brookhaven National Laboratory specializing in drug discovery, computational drug discovery, and computer-aided drug discovery.

ORCID

Publications per year

2021–2023

Publications

High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent Inhibitor

Austin Clyde, Stephanie Galanie, Daniel W. Kneller et al. · Journal of Chemical Information and Modeling · 2021 · 111 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +16

Pandemic Drugs at Pandemic Speed: Infrastructure for Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers

Agastya P. Bhati, Shunzhou Wan, Austin Clyde et al. · arXiv (Cornell University) · 2021 · 42 citations · Full text

Pharmacy, Chemistry, High-performance Computing +13

IMPECCABLE: Integrated Modeling PipelinE for COVID Cure by Assessing Better LEads

Dario Alfè, Yadu Babuji, Agastya P. Bhati et al. · UCL Discovery (University College London) · 2021 · 28 citations · Full text

Pharmacy, Bioinformatics, Pharmacology +14

High Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Non-Covalent Inhibitor

Austin Clyde, Stephanie Galanie, Daniel W. Kneller et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 25 citations · Full text

Life Sciences, Biology, Medicinal Chemistry +16

Scalable HPC & AI infrastructure for COVID-19 therapeutics

Hyungro Lee, André Merzky, Li Lynn Tan et al. · 2021 · 22 citations · Full text

Pharmacy, Bioinformatics, Artificial Intelligence +10

1–5 of 7